Company intelligence / Profile preview

nanoComposix

San Diego, California, United Statesfortislife.com ↗

Ownership: Private
Development stage: Commercial

Overview

nanoComposix provides GMP/ISO13485-certified nanomaterial manufacturing and custom development services for a wide range of life science applications. Their products are used in preclinical research, diagnostics, drug delivery systems, and emerging nanomedicine projects. They do not appear to have proprietary drugs in clinical trials but enable client programs with their technology.

Therapeutic areas: OncologyDermatologyOther
Modalities: NanoparticleDevice (for diagnostic assays)Polymer-drug conjugate therapy (via polymer nanoparticles)Lipid nanoparticle delivery therapy (via lipid nanoparticles)Silica nanoparticle delivery therapy (via silica nanoparticles)
Industry: Chemicals & Materials

Partnerships

not publicly disclosed; works with numerous pharma/life science companies as a CDMO/service provider

Beyond the preview

Go deeper on nanoComposix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on nanoComposix.

Explore the full profile